Browse or search current neurosurgery clinical trials
A Phase II Randomized, Blinded, and Placebo-controlled Trial of CMV RNA-Pulsed Dendritic Cells with Tetanus-Diphtheria Toxoid Vaccine in Patients with Newly-Diagnosed Glioblastoma.
Travel assistance is available to study participants living more than 100 miles away from the study center.
Glioblastoma Multiforme (GBM)
Investigational dendritic cell vaccine pp65-DC given with stronger doses of Temozolomide